Search Results - Drorit Merkel

  • Showing 1 - 5 results of 5
Refine Results
  1. 1
    Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes

    Changes in parameters of oxidative stress and free iron biomarkers during treatment with deferasirox in iron-overloaded patients with myelodysplastic syndromes by Hussam Ghoti, Eitan Fibach, Drorit Merkel, Galit Perez‐Avraham, Sigal Grisariu, E. A. Rachmilewitz

    Published 2010
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  2. 2
    Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia

    Safety and Efficacy of CD19-CAR T Cells in Richter's Transformation after Targeted Therapy for Chronic Lymphocytic Leukemia by Ohad Benjamini, Avichai Shimoni, Michal J. Besser, Noga Shem‐Tov, Ivetta Danylesko, Ronit Yerushalmi, Drorit Merkel, Tamar Tadmor, David Lavie, Riva Fineman, Elad Jacobi, Arnon Nagler, Abraham Avigdor

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study

    BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study by Galia Rahav, Yaniv Lustig, Jacob Lavee, Ohad Benjamini, Hila Magen, Tammy Hod, Noga Shem‐Tov, Einat Shmueli, Drorit Merkel, Ziv Ben‐Ari, Rebecca F. Halperin, Victoria Indenbaum, Liraz Olmer, Amit Huppert, Eytan Mor, Gili Regev‐Yochay, Carmit Cohen, Anat Wieder- Finesod, Itzchak Levy

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study

    BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study by Rahav, Galia, Lustig, Yaniv, Lavee, Jacob, Ohad Benjamini, Magen, Hila, Hod, Tammy, Noga Shem-Tov, Shmueli, Einat Shacham, Drorit Merkel, Ben-Ari, Ziv, Halperin, Rebecca, Indenbaum, Victoria, Olmer, Liraz, Huppert, Amit, Mor, Eytan, Regev-Yochay, Gili, Cohen, Carmit, Finesod, Anat Wieder-, Levy, Itzchak

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study

    Predicting infections in high‐risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study by Drorit Merkel, Kalman Filanovsky, Anat Gafter‐Gvili, Liat Vidal, Ariel Aviv, Moshe E. Gatt, Itay Silbershatz, Yair Herishanu, Ariela Arad, Tamar Tadmor, Najib Dally, Anatoly Nemets, Ory Rouvio, Aharon Ronson, Katrin Herzog‐Tzarfati, Luiza Akria, Andrei Braester, Ilana Hellmann, Shay Yeganeh, Arnon Nagler, Ronit Leiba, Moshe Mittelman, Yishai Ofran

    Published 2012
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: